F
Feops
Biotech & Life Sciences · Ghent, Belgium · Founded 2009
Cutting-edge technology that creates digital twins from cardiac scans MoreLess
Developer of a cardiac imaging technology designed to improve and expand personalized treatment for patients with structural heart disease. The company offers AI-enabled anatomical analyses to generate data-driven insights to improve transcatheter valve procedures based on personalized computer simulations, enabling healthcare professionals to improve both procedure efficiency and clinical outcomes. Keywords: Pharmaceuticals and Biotechnology, Cardiovascular Intervention, Computer Simulation, Invasive Device, Patient-Specific Insights, Structural Heart Intervention, Transcatheter Heart Valve, Transcatheter Valves System.
Talent graph
Feops's talent
Source: Dealroom Talent Intelligence.
Investors
6 investors on Feops's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where Feops has talent and traffic
team presence
Market sentiment
What the market is saying about Feops
An AI-synthesized read of the highest-engagement posts about Feops on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Feops on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.